GENETIC PHAMARCEUTICALS
With more than five decades of experience in the Ugenerics market, we’ve always put patients and healthcare providers at the center of our efforts—delivering cost-effective generic pharmaceuticals that meet diverse needs, without compromising on quality.
Our portfolio of ~80 therapeutically equivalent ANDA-based product families includes oral solids, liquids, powders, sprays, and transdermal patches that serve a range of conditions. We’re also one of the few vertically integrated generics manufacturers—from API to finished dose—backed by four API sites.
Our portfolio spans a broad range of therapeutic areas, dosage forms, and delivery technologies—from active pharmaceutical ingredients (APIs) to finished dose generics and sterile injectables.